NOVAREX Co.Ltd Total Liabilities
NOVAREX Co.Ltd total liabilities. Based on the latest financial reports, NOVAREX Co.Ltd (194700) has total liabilities worth ₩112.55 Billion KRW (≈ $76.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NOVAREX Co.Ltd (194700) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of NOVAREX Co.Ltd (2015–2025)
Total liabilities of NOVAREX Co.Ltd from 2015 to 2025. This chart illustrates how NOVAREX Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 194700 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
NOVAREX Co.Ltd Competitors by Total Liabilities
The table below lists competitors of NOVAREX Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Faraday Future Intelligent Electric Inc
NASDAQ:FFIE
|
USA | $339.87 Million |
|
Shin Foong Specialty and Applied Materials Co
TW:6582
|
Taiwan | NT$330.07 Million |
|
Bms Birlesik Metal Sanayi ve Ticaret AS
IS:BMSTL
|
Turkey | TL1.10 Billion |
|
Lastminute.com NV
SW:LMN
|
Switzerland | CHF517.92 Million |
|
GKW Limited
NSE:GKWLIMITED
|
India | Rs6.11 Billion |
|
Novus Holdings Ltd
JSE:NVS
|
South Africa | ZAC1.36 Billion |
|
Galantas Gold Corp
V:GAL
|
Canada | CA$3.91 Million |
|
Maywood Acquisition Corp. 2 Class A Ordinary Share
NASDAQ:MYX
|
USA | $165.57K |
Liability Composition Analysis (2015–2025)
This chart breaks down NOVAREX Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NOVAREX Co.Ltd assets under control.
Liquidity & Leverage Metrics
NOVAREX Co.Ltd Total Liabilities Ratios Explained
NOVAREX Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NOVAREX Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual total liabilities of NOVAREX Co.Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩104.91 Billion ≈ $71.10 Million |
+51.29% |
| 2024-12-31 | ₩69.35 Billion ≈ $47.00 Million |
+7.82% |
| 2023-12-31 | ₩64.32 Billion ≈ $43.59 Million |
-27.91% |
| 2022-12-31 | ₩89.21 Billion ≈ $60.46 Million |
-22.40% |
| 2021-12-31 | ₩114.96 Billion ≈ $77.91 Million |
+15.09% |
| 2020-12-31 | ₩99.89 Billion ≈ $67.70 Million |
+59.62% |
| 2019-12-31 | ₩62.58 Billion ≈ $42.41 Million |
+128.43% |
| 2018-12-31 | ₩27.40 Billion ≈ $18.57 Million |
+37.52% |
| 2017-12-31 | ₩19.92 Billion ≈ $13.50 Million |
+27.79% |
| 2016-12-31 | ₩15.59 Billion ≈ $10.56 Million |
-21.77% |
| 2015-12-31 | ₩19.93 Billion ≈ $13.51 Million |
-- |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more